>>Analytical Standards>>Glufosinate-d3 (hydrochloride)

Glufosinate-d3 (hydrochloride)

Catalog No.GC49271

An internal standard for the quantification of glufosinate

Products are for research use only. Not for human use. We do not sell to patients.

Glufosinate-d3 (hydrochloride) Chemical Structure

Cas No.: 1323254-05-2

Size 가격 재고 수량
1 mg
US$814.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Glufosinate-d3 is intended for use as an internal standard for the quantification of glufosinate by GC- or LC-MS. Glufosinate is a broad-spectrum herbicide and racemic mixture of L-phosphinothricin, a phytotoxic compound, and D-phosphinothricin, its inactive enantiomer.1 It is an irreversible inhibitor of glufosinate synthetase 1 (GS1) and GS2 (Kis = 1.1. and 4.8 µM, respectively), enzymes that are required for nitrogen metabolism in plants. Glufosinate induces the production of reactive oxygen species (ROS) and lipid peroxidation in plant cell membranes. It reduces dry biomass of the weeds E. canadensis and L. rigidum with ED50 values of 26 and 763 g/hectare, respectively. Glufosinate has no observed adverse effects in rats and mice when administered at doses of 4.1 and 17 mg/kg per day for three months. Formulations containing glufosinate have been used as foliar herbicides in agriculture.

1.Takano, H.K., and Dayan, F.E.Glufosinate-ammonium: A review of the current state of knowledgePest Manag. Sci.76(12)3911-3925(2020)

리뷰

Review for Glufosinate-d3 (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glufosinate-d3 (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.